Cosmetics brand in the 'SETEC MEGA SHOW'continuously praised
ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Suave Brands and Elida Beauty Complete Merger to Form Personal Care Giant Evermark with Annual Retail Sales Near $1.9 Billion
-
Estée Lauder Companies Announces $1.14 Billion in Restructuring Charges
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
Shiseido Americas Plans Major Layoffs amid Sharp Sales Decline
-
Procter & Gamble Raises US Personal Care Prices Due to Tariff Pressure
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
Recommend Reading
-
BASF and Hannong Chemical Joint Venture Nonionic Surfactant Plant Begins Operation in South Korea
-
LBB Specialties to Distribute Imerys' Mineral Ingredients in North America
-
BASF and IFF Collaborate to Accelerate Innovation in Enzymes and Polymers
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
-
Albéa Acquires Amfora Packaging, Strengthening Its Position in Latin America
-
Anastrozole Side Effects: What You Need to Know
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
The Last 10% Tariff Trap: A New Chapter in U.S.–China Negotiations on “Fentanyl Tariffs”
-
Summary of Pure Benzene Trends in August (August 1, 2025 - August 29, 2025) in China
-
Sodium Dodecyl Sulfate (SDS): Properties, Uses, and Safety